The Association between Gallstone Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis

Rasoul Rahimi1, Saeid Heidari-Soureshjani2, Catherine Mt Sherwin3

  • 1Department of Surgery, Shahrekord University of Medical Sciences, Shahrekord, Iran.

PubMed

Insights

Gallstone disease (GSD) significantly increases cardiovascular disease (CVD) risk. Early interventions for GSD may help prevent CVD, highlighting a crucial link between these conditions.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Epidemiology

Background:

  • Gallstone disease (GSD) is a known risk factor for multiple health complications.
  • Understanding the link between GSD and cardiovascular disease (CVD) is crucial for public health.

Purpose of the Study:

  • To systematically review and meta-analyze the association between Gallstone Disease and Cardiovascular Disease.
  • To quantify the risk of CVD in individuals with GSD.

Main Methods:

  • A comprehensive literature search was performed across major databases (1980-2023).
  • Included 21 studies with over 2 million participants.
  • Statistical analyses included heterogeneity and publication bias assessments using Stata 17.

Main Results:

  • A significant association was found between GSD and an increased risk of CVD (RR 1.46, 95% CI: 1.32-1.63).
  • No publication bias was detected.
  • Subgroup analyses indicated higher CVD risk in specific study populations and designs.

Conclusions:

  • Gallstone disease is significantly associated with an increased incidence of cardiovascular disease.
  • Targeted interventions for GSD patients may mitigate CVD risk.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
484
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3
Coronary Artery Disease IV: Medical Management01:26

Coronary Artery Disease IV: Medical Management

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
4
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Coronary Artery Disease V: Surgical Management01:27

Coronary Artery Disease V: Surgical Management

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3